Reported 8 months ago
To celebrate the 40th anniversary of the Biotechnology Development Center (DCB), the organization hosted a two-day regenerative medicine forum in collaboration with the Taiwan Extracellular Vesicle Industry-Academia Alliance, Taiwan Extracellular Vesicle Society, and Xunlian Group. Key figures emphasized the significance of extracellular vesicles as a new technology for drug design, with Taiwan actively participating in research and industrialization processes. Experts presented advancements in the field, showcasing potential applications in skincare, hair medicine, and medical aesthetics, highlighting the international emphasis on extracellular vesicles and the need for collaboration and resource integration in Taiwan's biotechnology industry.
Source: YAHOO